CLASS II Device recall · Reported 19 Jul 2017 · FDA Enforcement Report

Vidas Testosterone recalled by bioMerieux

bioMerieux is recalling Vidas Testosterone, distributed in 14 states. The recall was initiated on 15 May 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots 1004878310 & 1005001080
Quantity recalled742

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2339-2017
FDA event ID
77292
Recalling firm
bioMerieux, Durham, NC
Classification
Class II
Status
Terminated
Recall initiated
15 May 2017
FDA classified
11 Jul 2017
Reported
19 Jul 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 May 2017Recall initiated by company
11 Jul 2017Classified by FDA+57 days
19 Jul 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.

Product as listed by the FDA

VIDAS Testosterone, Ref 30418

Where it was distributed

AR, CA, CO, GA, IL, IA, MI, MN, MT, NY, OK, TN, TX, WY, Columbia, Costa Rica, El Salvador, France, Hong Kong, Jordan, Nicaragua, Russian Fed., Sri Lanka, Sweden, Ukraine

ArkansasCaliforniaColoradoGeorgiaIowaIllinoisMichiganMinnesotaMontanaNew YorkOklahomaTennesseeTexasWyoming

Questions about this recall

Is Vidas Testosterone recalled?

Yes. bioMerieux recalled Vidas Testosterone on 15 May 2017. The recall is Class II and its status is Terminated. Recall number Z-2339-2017.

Why was it recalled?

Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.

Which lots are affected?

Lots 1004878310 & 1005001080

Where was it sold?

AR, CA, CO, GA, IL, IA, MI, MN, MT, NY, OK, TN, TX, WY, Columbia, Costa Rica, El Salvador, France, Hong Kong, Jordan, Nicaragua, Russian Fed., Sri Lanka, Sweden, Ukraine

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from bioMerieux

All 476

Other Other Medical Devices recalls

All 13,778